AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2026
Feb 6, 2026
35334_dirs_2026-02-06_a8952acb-91f6-4bef-afd9-a13aec5892c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2026-02-05
Reporting Person: CHEMEROW DAVID I. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-05 | Common Stock | A | 2800 | $1.23 | Acquired | 3441 | Indirect |
More from AIM ImmunoTech Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 10